FERRERO, Dario
 Distribuzione geografica
Continente #
NA - Nord America 1822
EU - Europa 774
AS - Asia 396
AF - Africa 23
OC - Oceania 11
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3038
Nazione #
US - Stati Uniti d'America 1786
IT - Italia 324
DE - Germania 160
CN - Cina 143
IN - India 70
VN - Vietnam 59
GB - Regno Unito 48
JP - Giappone 47
FR - Francia 38
PL - Polonia 32
CA - Canada 27
KR - Corea 23
SE - Svezia 21
CH - Svizzera 19
GR - Grecia 16
UA - Ucraina 14
ES - Italia 13
ZA - Sudafrica 13
AT - Austria 11
NL - Olanda 11
RO - Romania 11
RU - Federazione Russa 11
SG - Singapore 10
AU - Australia 9
CZ - Repubblica Ceca 9
TR - Turchia 9
IE - Irlanda 8
TW - Taiwan 7
BE - Belgio 6
CL - Cile 5
MX - Messico 5
CR - Costa Rica 4
ID - Indonesia 4
HU - Ungheria 3
PE - Perù 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
AD - Andorra 2
DK - Danimarca 2
EU - Europa 2
HK - Hong Kong 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
LT - Lituania 2
ML - Mali 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
FI - Finlandia 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 3038
Città #
Fairfield 231
Houston 153
Woodbridge 120
Ashburn 118
Santa Cruz 102
Seattle 99
Cambridge 94
Buffalo 92
Ann Arbor 71
Wilmington 63
Torino 55
Dong Ket 45
Treviso 38
Beijing 36
Pisa 28
Warsaw 28
San Diego 23
Los Angeles 22
New York 22
Shanghai 22
Bengaluru 21
Chicago 21
Las Vegas 20
Mountain View 19
Fleming Island 17
Stockholm 16
Boardman 15
University Park 15
Wuhan 15
Ottawa 13
Changsha 12
Collegno 12
Turin 12
Phoenix 11
Tokyo 11
Vienna 11
Genova 10
Brooklyn 9
Dallas 8
Dublin 8
Muizenberg 8
Nürnberg 8
Singapore 8
Clearwater 7
Lake Forest 7
London 7
Milan 7
Toronto 7
Berlin 6
Leawood 6
Nanjing 6
Paris 6
Rochester 6
Taipei 6
Des Moines 5
Guadalajara 5
Hangzhou 5
Hebei 5
Provo 5
Riva 5
Verona 5
Ürümqi 5
Bologna 4
Boston 4
Chandler 4
Chennai 4
Florence 4
Perpignan 4
Saint Petersburg 4
San Francisco 4
Seoul 4
Vercelli 4
Athens 3
Bari 3
Beachwood 3
Brentwood 3
Chengdu 3
Dearborn 3
Duncan 3
Easton 3
Hanoi 3
Homebush 3
Hyderabad 3
Jackson Heights 3
Jersey City 3
Lima 3
Manchester 3
Miami 3
Milwaukee 3
Osaka 3
Pavia 3
Portland 3
Rome 3
San Jose 3
Thessaloniki 3
Tianjin 3
Amsterdam 2
Atlanta 2
Azzano Decimo 2
Bamako 2
Totale 1993
Nome #
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?, file e27ce427-0911-2581-e053-d805fe0acbaa 381
FLAI induction regimen in elderly patients with acute myeloid leukemia, file e27ce42f-5416-2581-e053-d805fe0acbaa 280
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients, file e27ce42d-4424-2581-e053-d805fe0acbaa 246
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study, file e27ce42d-f1f6-2581-e053-d805fe0acbaa 225
Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents, file e27ce432-472a-2581-e053-d805fe0acbaa 198
Can pegylated interferon improve the outcome of polycythemia vera patients?, file e27ce42b-c424-2581-e053-d805fe0acbaa 164
Ruxolitinib in steroid refractory graft-vs.-host disease: A case report, file e27ce429-fbaf-2581-e053-d805fe0acbaa 155
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib, file e27ce42f-09e8-2581-e053-d805fe0acbaa 153
Anemia in the Elderly: not Always what it Seems., file e27ce42b-cfd6-2581-e053-d805fe0acbaa 152
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome, file e27ce42a-1d2a-2581-e053-d805fe0acbaa 131
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia, file e27ce42e-1c4c-2581-e053-d805fe0acbaa 101
Effects of erythropoiesis-stimulating agents on overall survival of international prognostic scoring system low/intermediate-1 risk, transfusion-inde-pendent myelodysplastic syndrome patients: A cohort study, file e27ce42e-58a4-2581-e053-d805fe0acbaa 99
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients, file e27ce42f-87c9-2581-e053-d805fe0acbaa 95
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML, file e27ce42f-4c8e-2581-e053-d805fe0acbaa 92
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis, file e27ce42f-4a50-2581-e053-d805fe0acbaa 85
Real life use of bendamustine in elderly patients with lymphoid neoplasia, file e27ce432-2046-2581-e053-d805fe0acbaa 73
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial, file e27ce42f-5796-2581-e053-d805fe0acbaa 71
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib, file e27ce42e-42b5-2581-e053-d805fe0acbaa 68
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment., file e27ce42b-4011-2581-e053-d805fe0acbaa 62
Corticosteroids can reverse severe imatinib-induced hepatotoxicity, file e27ce426-9ed4-2581-e053-d805fe0acbaa 57
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice, file e27ce430-0dcb-2581-e053-d805fe0acbaa 45
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation, file e27ce432-8806-2581-e053-d805fe0acbaa 44
In patients with Polycythemia Vera older age is the prognostic factor at highest impact on survival, file e27ce427-0f45-2581-e053-d805fe0acbaa 41
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA, file e27ce426-ff24-2581-e053-d805fe0acbaa 34
Hematopoietic stem and progenitor cell composition in peripheral blood and in mobilized CD34+ cells harvests., file e27ce427-5214-2581-e053-d805fe0acbaa 24
Differences among young adults, adults and elderly chronic myeloid leukemia patients., file e27ce42a-c137-2581-e053-d805fe0acbaa 24
Evolving therapeutic approaches for older patients with acute myeloid leukemia in 2021, file e27ce434-db3d-2581-e053-d805fe0acbaa 16
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia, file e27ce432-4cb5-2581-e053-d805fe0acbaa 15
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia, file e27ce433-4b6f-2581-e053-d805fe0acbaa 13
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation, file e27ce430-1511-2581-e053-d805fe0acbaa 6
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice, file e27ce432-4903-2581-e053-d805fe0acbaa 6
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study, file e7fe1f2e-1278-4f69-83cb-6ddec4ced9f7 6
Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia, file e27ce42f-a1ee-2581-e053-d805fe0acbaa 5
FLAI induction regimen in elderly patients with acute myeloid leukemia, file b1eb6360-1246-4aaa-b6df-7f4de75b613b 3
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment., file e27ce427-0913-2581-e053-d805fe0acbaa 3
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study., file e27ce42a-ac7f-2581-e053-d805fe0acbaa 2
In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy., file e27ce426-a007-2581-e053-d805fe0acbaa 1
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia., file e27ce42a-a41a-2581-e053-d805fe0acbaa 1
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series, file e27ce42e-1da5-2581-e053-d805fe0acbaa 1
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline, file e27ce42f-7508-2581-e053-d805fe0acbaa 1
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?, file e27ce432-d349-2581-e053-d805fe0acbaa 1
Totale 3180
Categoria #
all - tutte 4027
article - articoli 0
book - libri 0
conference - conferenze 168
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20183 0000 00 00 0003
2018/2019307 212212 96 333 232512258
2019/2020598 40302154 2631 3647 167524351
2020/2021730 48664749 5069 25108 37706497
2021/2022827 927537125 8118 6444 415413462
2022/2023577 245411782 3445 3842 4147530
Totale 3180